78 related articles for article (PubMed ID: 27699666)
1. High-Performance Liquid Chromatography Analysis of CYP2C8-Catalyzed Paclitaxel 6α-Hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():103-107. PubMed ID: 27699666
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatography analysis of CYP2C8-catalyzed paclitaxel 6alpha-hydroxylation.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():103-7. PubMed ID: 16719379
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of 12 allelic variants of CYP2C8 by assessment of paclitaxel 6α-hydroxylation and amodiaquine N-deethylation.
Tsukada C; Saito T; Maekawa M; Mano N; Oda A; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2015 Oct; 30(5):366-73. PubMed ID: 26427316
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomes.
Ma B; Subramanian R; Schrag ML; Rodrigues AD; Tang C
Drug Metab Dispos; 2004 May; 32(5):473-8. PubMed ID: 15100167
[TBL] [Abstract][Full Text] [Related]
5. Human liver microsomal metabolism of paclitaxel and drug interactions.
Desai PB; Duan JZ; Zhu YW; Kouzi S
Eur J Drug Metab Pharmacokinet; 1998; 23(3):417-24. PubMed ID: 9842986
[TBL] [Abstract][Full Text] [Related]
6. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance.
Wattanachai N; Polasek TM; Heath TM; Uchaipichat V; Tassaneeyakul W; Tassaneeyakul W; Miners JO
Eur J Clin Pharmacol; 2011 Aug; 67(8):815-24. PubMed ID: 21305272
[TBL] [Abstract][Full Text] [Related]
7. Determination of CYP4A11-catalyzed lauric acid 12-hydroxylation by high-performance liquid chromatography with radiometric detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():143-7. PubMed ID: 16719385
[TBL] [Abstract][Full Text] [Related]
8. Determination of CYP2C9-catalyzed diclofenac 4'-hydroxylation by high-performance liquid chromatography.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():109-13. PubMed ID: 16719380
[TBL] [Abstract][Full Text] [Related]
9. Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes.
Kim KA; Chung J; Jung DH; Park JY
Eur J Clin Pharmacol; 2004 Oct; 60(8):575-81. PubMed ID: 15365656
[TBL] [Abstract][Full Text] [Related]
10. The Role of CYP2C8 and CYP2C9 Genotypes in Losartan-Dependent Inhibition of Paclitaxel Metabolism in Human Liver Microsomes.
Mukai Y; Senda A; Toda T; Eliasson E; Rane A; Inotsume N
Basic Clin Pharmacol Toxicol; 2016 Jun; 118(6):408-14. PubMed ID: 26551762
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of CYP2C8.13 and CYP2C8.14: catalytic activities toward paclitaxel.
Hanioka N; Matsumoto K; Saito Y; Narimatsu S
Basic Clin Pharmacol Toxicol; 2010 Jul; 107(1):565-9. PubMed ID: 20148860
[TBL] [Abstract][Full Text] [Related]
12. Taxane's substituents at C3' affect its regioselective metabolism: different in vitro metabolism of cephalomannine and paclitaxel.
Zhang JW; Ge GB; Liu Y; Wang LM; Liu XB; Zhang YY; Li W; He YQ; Wang ZT; Sun J; Xiao HB; Yang L
Drug Metab Dispos; 2008 Feb; 36(2):418-26. PubMed ID: 18039807
[TBL] [Abstract][Full Text] [Related]
13. The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6alpha-hydroxypaclitaxel, a major metabolite of paclitaxel.
Kang MH; Figg WD; Ando Y; Blagosklonny MV; Liewehr D; Fojo T; Bates SE
Clin Cancer Res; 2001 Jun; 7(6):1610-7. PubMed ID: 11410497
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel metabolism in rat and human liver microsomes is inhibited by phenolic antioxidants.
Václavíková R; Horský S; Simek P; Gut I
Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):200-9. PubMed ID: 12920504
[TBL] [Abstract][Full Text] [Related]
15. Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity.
Kerdpin O; Elliot DJ; Boye SL; Birkett DJ; Yoovathaworn K; Miners JO
Biochemistry; 2004 Jun; 43(24):7834-42. PubMed ID: 15196026
[TBL] [Abstract][Full Text] [Related]
16. An isocratic high-performance liquid chromatography assay for CYP7A1-catalyzed cholesterol 7alpha-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():149-52. PubMed ID: 16719386
[TBL] [Abstract][Full Text] [Related]
17. An Isocratic High-Performance Liquid Chromatography Assay for CYP7A1-Catalyzed Cholesterol 7α-Hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 2006; 320():149-152. PubMed ID: 27699668
[TBL] [Abstract][Full Text] [Related]
18. Different in vitro metabolism of paclitaxel and docetaxel in humans, rats, pigs, and minipigs.
Vaclavikova R; Soucek P; Svobodova L; Anzenbacher P; Simek P; Guengerich FP; Gut I
Drug Metab Dispos; 2004 Jun; 32(6):666-74. PubMed ID: 15155559
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6-dependent bufuralol 1'-hydroxylation assayed by reverse-phase ion-pair high-performance liquid chromatography with fluorescence detection.
Crespi CL; Chang TK; Waxman DJ
Methods Mol Biol; 2006; 320():121-5. PubMed ID: 16719382
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of paclitaxel and its metabolites, 6α-hydroxypaclitaxel and p-3'-hydroxypaclitaxel, in human plasma using column-switching liquid chromatography/tandem mass spectrometry.
Yamaguchi H; Fujikawa A; Ito H; Tanaka N; Furugen A; Miyamori K; Takahashi N; Ogura J; Kobayashi M; Yamada T; Mano N; Iseki K
Biomed Chromatogr; 2013 Apr; 27(4):539-44. PubMed ID: 23018973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
